A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Condition:   Tuberculosis, Pulmonary Intervention:   Drug: Interleukin-2 Sponsor:   Beijing Chest Hospital Recruiting

Source: ClinicalTrials.gov - February 23, 2021 Category: Research Source Type: clinical trials